Oxford Sciences Innovation (OSI), which invests in world-leading science and technology from the University of Oxford, is expanding at The Oxford Science Park, one of the UK’s leading parks for science and technology companies. Driven by its rapid rate of growth and creation of spin-out companies, OSI is taking 17,260 sq ft of office and laboratory space on the second floor of the state-of-the-art Schrödinger Building. The space will be used by three of its spin-out companies – Orbit Discovery (peptide drugs for chronic diseases), OMass Technologies (mass spectrometry of protein complexes for drug discovery) and Vaccitech (novel vaccines for flu and cancer). They join five other OSI spin-outs on The Oxford Science Park, highlighting it as the location of choice for life science companies in Oxford.
OSI was established in 2015 to exploit and commercialise research findings from academic departments across the University. Since then it has raised over £600m and set up over 50 companies. As the portfolio companies have grown they need extra capacity and laboratory space, and The Oxford Science Park’s Schrödinger Building is the ideal location for the next phase of their growth. Vaccitech, OMass and Orbit are expected to move in during September, joining the other OSI spin-outs Evox Therapeutics, Argonaut Therapeutics, OxSight, Ultromics and Circadian Therapeutics which are already resident on the Park.
‘Having invested almost £100m in its portfolio companies since inception, OSI is a key player in the UK innovation network. The Oxford Science Park is delighted to strengthen its links with OSI and I have little doubt its spin-out companies will thrive and grow here. In addition to our exemplary working environment, our flexible leasing policy and the abundance of collaborative opportunities presented by our existing commercial eco-system support growth and value creation,’ said Piers Scrimshaw-Wright, Managing Director of The Oxford Science Park.
Carter Jonas represented The Oxford Science Park and Bidwells represented OSI.